Influenza vaccination rates are declining while flu cases continue to rise, creating significant challenges for health system capacity and operations. In this episode, Amanda Cohn, MD, Medical Head of Influenza and COVID, North America, Vaccines, Sanofi, explains the clinical and operational impact of low vaccination coverage on health systems and discuss evidence-based strategies that leaders can implement to improve immunization rates and strengthen system resilience during respiratory season.
Selected Podcast
From Reactive to Resilient: Rethinking Health System Strategy for Flu Season
Featured Speaker:
Amanda Cohn, MD
Dr. Amanda Cohn is the Medical Head of Influenza and COVID Vaccines for Sanofi, North America. She is responsible for leading medical strategy and initiatives for Sanofi's influenza and COVID vaccine programs across the region.
With over twenty years of distinguished public health experience, Dr. Cohn comes to Sanofi from the Centers for Disease Control and Prevention (CDC), where she held several senior leadership roles. As Executive Secretary of the Advisory Committee on Immunization Practices (ACIP), she spearheaded the introduction of the Evidence to Recommendations framework for U.S. vaccine policy development. She also served as Chief Medical Officer of the National Center for Immunization and Respiratory Diseases and as deputy director of the Immunization Services Division, which manages the Vaccines for Children program. From 2020–2024, she was a member of the FDA's Vaccines and Related Biologics Policy Advisory Committee. She retired as a Captain in the US Public Health Service.
A graduate of Emory University in Atlanta, GA, Dr. Cohn earned her Doctor of Medicine degree before completing her pediatric residency at the Boston Combined Residency in Pediatrics.